semaglutide cardiovascular outcomes study news HUGE NEWS! Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetics, they REDUCE risk of death, heart attack, stroke, heart failure, AND ALL CAUSE MORTALITY! Groundbreaking SELECT Cardiovascular risk reduction with once-weekly

P., Pakarinen, A., Alen, M., Kraemer, W

These medications may be dispensed by state-licensed 503A compounding pharmacies as part of personalized care

Strength training is especially important here, since it helps you hold on to more muscle as you lose weight, which can help keep your metabolism higher

Lifestyle Factors Complementary strategies for optimal metabolic outcomes

A comprehensive symptom list provides a complete health picture

The results of one population-based cohort study, designed to emulate a randomised controlled trial, suggest that the combined use of GLP-1RAs and SGLT-2is is associated with a reduced risk of major adverse CV events and serious kidney events, compared with using either drug class alone